A Beydoun

Summary

Affiliation: University of Michigan
Country: USA

Publications

  1. ncbi Efficacy of oxcarbazepine in the treatment of painful diabetic neuropathy
    Ahmad Beydoun
    University of Michigan Health System, Ann Arbor, Michigan 48109 0036, USA
    Clin J Pain 20:174-8. 2004
  2. ncbi Safety and efficacy of two pregabalin regimens for add-on treatment of partial epilepsy
    A Beydoun
    University of Michigan Health System, 1500 E Medical Center Dr, UH 1 B 300 0036, Ann Arbor, MI 48109 0036, USA
    Neurology 64:475-80. 2005
  3. ncbi Safety and efficacy of oxcarbazepine: results of randomized, double-blind trials
    A Beydoun
    University of Michigan Medical Center, Ann Arbor 48109, USA
    Pharmacotherapy 20:152S-158S. 2000
  4. ncbi Full neurologic recovery after fulminant thrombotic thrombocytopenic purpura with status epilepticus
    Ahmad Beydoun
    Department of Neurology, University of Michigan Hospitals, 1500 East Medical Center Drive, UH1B300 0036, Ann Arbor, MI 48109, USA
    Seizure 13:549-52. 2004
  5. ncbi Appropriate use of medications for seizures. Guiding principles on the path of efficacy
    Ahmad Beydoun
    University of Michigan Health System, Clinical Neurophysiology Laboratories, 1500 E Medical Center Dr, 1B300 0036, Ann Arbor, MI 48109, USA
    Postgrad Med 111:69-70, 73-8, 81-2. 2002
  6. ncbi Sustained efficacy and long-term safety of oxcarbazepine: one-year open-label extension of a study in refractory partial epilepsy
    Ahmad Beydoun
    Department of Neurology, University of Michigan Health System, Ann Arbor, Michigan 48109 0036, USA
    Epilepsia 44:1160-5. 2003
  7. ncbi Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial
    M Backonja
    Department of Neurology, University of Wisconsin, Madison 53792, USA
    JAMA 280:1831-6. 1998
  8. ncbi Seizure semiology and neuroimaging findings in patients with midline spikes
    E Kutluay
    Department of Neurology, University of Michigan, Ann Arbor, Michigan 48109, USA
    Epilepsia 42:1563-8. 2001
  9. ncbi Measuring the coherence of intracranial electroencephalograms
    H P Zaveri
    Department of Neurology, Yale University School of Medicine, New Haven, CT 06520, USA
    Clin Neurophysiol 110:1717-25. 1999
  10. ncbi Oxcarbazepine
    Ahmad Beydoun
    University of Michigan Medical Center, Ann Arbor 48109, USA
    Expert Opin Pharmacother 3:59-71. 2002

Detail Information

Publications28

  1. ncbi Efficacy of oxcarbazepine in the treatment of painful diabetic neuropathy
    Ahmad Beydoun
    University of Michigan Health System, Ann Arbor, Michigan 48109 0036, USA
    Clin J Pain 20:174-8. 2004
    ..To evaluate the safety, tolerability, and efficacy of oxcarbazepine in the treatment of painful diabetic neuropathy...
  2. ncbi Safety and efficacy of two pregabalin regimens for add-on treatment of partial epilepsy
    A Beydoun
    University of Michigan Health System, 1500 E Medical Center Dr, UH 1 B 300 0036, Ann Arbor, MI 48109 0036, USA
    Neurology 64:475-80. 2005
    ..To evaluate the efficacy, tolerability, and safety of two pregabalin regimens administered as adjunctive therapy to that of placebo in patients with medically refractory partial epilepsy...
  3. ncbi Safety and efficacy of oxcarbazepine: results of randomized, double-blind trials
    A Beydoun
    University of Michigan Medical Center, Ann Arbor 48109, USA
    Pharmacotherapy 20:152S-158S. 2000
    ..The results of oxcarbazepine in treating epilepsy are discussed...
  4. ncbi Full neurologic recovery after fulminant thrombotic thrombocytopenic purpura with status epilepticus
    Ahmad Beydoun
    Department of Neurology, University of Michigan Hospitals, 1500 East Medical Center Drive, UH1B300 0036, Ann Arbor, MI 48109, USA
    Seizure 13:549-52. 2004
    ....
  5. ncbi Appropriate use of medications for seizures. Guiding principles on the path of efficacy
    Ahmad Beydoun
    University of Michigan Health System, Clinical Neurophysiology Laboratories, 1500 E Medical Center Dr, 1B300 0036, Ann Arbor, MI 48109, USA
    Postgrad Med 111:69-70, 73-8, 81-2. 2002
    ..Because the presence of epilepsy can have a significant bearing on quality of life, the decision to discontinue treatment should be made in congruence with the patient's needs, wishes, and commitments...
  6. ncbi Sustained efficacy and long-term safety of oxcarbazepine: one-year open-label extension of a study in refractory partial epilepsy
    Ahmad Beydoun
    Department of Neurology, University of Michigan Health System, Ann Arbor, Michigan 48109 0036, USA
    Epilepsia 44:1160-5. 2003
    ..To evaluate the long-term efficacy, tolerability, and safety of oxcarbazepine (OXC) in medically refractory partial epilepsy...
  7. ncbi Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial
    M Backonja
    Department of Neurology, University of Wisconsin, Madison 53792, USA
    JAMA 280:1831-6. 1998
    ..Pain is the most disturbing symptom of diabetic peripheral neuropathy. As many as 45% of patients with diabetes mellitus develop peripheral neuropathies...
  8. ncbi Seizure semiology and neuroimaging findings in patients with midline spikes
    E Kutluay
    Department of Neurology, University of Michigan, Ann Arbor, Michigan 48109, USA
    Epilepsia 42:1563-8. 2001
    ..Automotor seizures and tonic seizures are the most common semiologies. Focal radiologic abnormalities tend to be lateralized to one of the frontal lobes...
  9. ncbi Measuring the coherence of intracranial electroencephalograms
    H P Zaveri
    Department of Neurology, Yale University School of Medicine, New Haven, CT 06520, USA
    Clin Neurophysiol 110:1717-25. 1999
    ..The performance characteristics of the coherence estimator and statistical testing of coherence estimates are described in this manuscript...
  10. ncbi Oxcarbazepine
    Ahmad Beydoun
    University of Michigan Medical Center, Ann Arbor 48109, USA
    Expert Opin Pharmacother 3:59-71. 2002
    ..In this review, recommendations on the optimal clinical use of oxcarbazepine are given based on its pharmacokinetic profile, efficacy and tolerability in those various conditions...
  11. ncbi Diagnostic and localizing value of ictal SPECT in patients with nonconvulsive status epilepticus
    Ekrem Kutluay
    Department of Neurology, University of Michigan Health System, Ann Arbor, MI, USA
    Epilepsy Behav 6:212-7. 2005
    ..This is especially the case when the EEG findings are inconclusive and for patients in whom surgical treatment is being considered...
  12. ncbi Predictive value of early EEG after epilepsy surgery
    Scott Mintzer
    Jefferson Comprehensive Epilepsy Center, Department of Neurology, Thomas Jefferson University, Philadelphia, PA, U S A
    J Clin Neurophysiol 22:410-4. 2005
    ..It was also not predictive of outcome in the 44 patients (76%) who did not suffer early recurrence. The authors conclude that EEG performed a few months after epilepsy surgery is not useful as a predictor of long-term seizure outcome...
  13. ncbi Efficacy and tolerability of the new antiepileptic drugs, II: Treatment of refractory epilepsy: report of the TTA and QSS Subcommittees of the American Academy of Neurology and the American Epilepsy Society
    Jacqueline A French
    Neurological Institute, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
    Epilepsia 45:410-23. 2004
    ....
  14. ncbi Efficacy and tolerability of the new antiepileptic drugs, I: Treatment of new-onset epilepsy: report of the TTA and QSS Subcommittees of the American Academy of Neurology and the American Epilepsy Society
    Jacqueline A French
    Neurological Institute, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
    Epilepsia 45:401-9. 2004
    ..S. Food and Drug Administration] in the treatment of children and adults with newly diagnosed partial and generalized epilepsies...
  15. ncbi Nonconvulsive status epilepticus manifesting as pure alexia (alexia without agraphia)
    Ekrem Kutluay
    Department of Neurology, Kent Hospital, Izmir, Turkey
    Epilepsy Behav 10:626-8. 2007
    ..A follow-up MRI scan of the brain obtained 1 month later was normal. NCSE can have unusual clinical manifestations, and a high index of suspicion is necessary to correctly diagnose these patients...
  16. ncbi Long-term outcome of nonsurgical candidates with medically refractory localization-related epilepsy
    Linda M Selwa
    Department of Neurology, University of Michigan Medical School, 1500 East Medical Center Drive, 1914 0316 Taubman, Ann Arbor, MI 48109 0316, USA
    Epilepsia 44:1568-72. 2003
    ..In this study, we evaluated the outcome of medical treatment in patients with medically refractory partial epilepsy who were evaluated for possible epilepsy surgery but deemed to be inadequate surgical candidates...
  17. ncbi Oxcarbazepine in neuropathic pain
    Wassim Nasreddine
    Beirut Governmental University Hospital, Jnah, Beirut, Lebanon
    Expert Opin Investig Drugs 16:1615-25. 2007
    ..Its efficacy in treating painful diabetic neuropathy is less clear; however, it seems to be useful when tolerated at doses of 1800 mg/day...
  18. ncbi Reversible facial myoclonus with topiramate therapy for epilepsy
    Ekrem Kutluay
    Epilepsia 48:2001-2. 2007
  19. ncbi Safety and tolerability of oxcarbazepine in elderly patients with epilepsy
    Ekrem Kutluay
    Department of Neurology, University of Michigan Health System, 1500 East Medical Center Drive, UH1B300/0036, Ann Arbor, MI 48109, USA
    Epilepsy Behav 4:175-80. 2003
    ..The results indicate that oxcarbazepine is safe to use in elderly patients and that its tolerability in this age group is similar to that of younger adult patients...
  20. ncbi Valproate-induced thrombocytopenia: a prospective monotherapy study
    Wassim Nasreddine
    Beirut Governmental University Hospital, Beirut, Lebanon
    Epilepsia 49:438-45. 2008
    ..Our objective was to evaluate the relationship between trough VPA plasma levels and platelet counts and assess risk factors for the development of thrombocytopenia...
  21. ncbi Efficacy and tolerability of pregabalin in partial epilepsy
    Ahmad Beydoun
    American University of Beirut Medical Center, Beirut, Lebanon
    Expert Rev Neurother 8:1013-24. 2008
    ..Meta-analyses of efficacy and tolerability indicated that pregabalin is an efficacious and relatively well-tolerated antiepileptic drug...
  22. ncbi Sporadic Creutzfeldt-Jakob disease presenting with nonconvulsive status epilepticus
    David Cohen
    Department of Neurology, University of Michigan Health System, UH1B300/0036 Ann Arbor, MI 48109, USA
    Epilepsy Behav 5:792-6. 2004
    ..We report a case of CJD that occurred in a 26-year-old patient who presented with a receptive (Wernicke's) aphasia secondary to nonconvulsive status epilepticus...
  23. ncbi Neuropathic pain: from mechanisms to treatment strategies
    Ahmad Beydoun
    Department of Neurology, University of Michigan Medical School, Ann Arbor, Michigan, USA
    J Pain Symptom Manage 25:S1-3. 2003
  24. ncbi Novel mental retardation-epilepsy syndrome linked to Xp21.1-p11.4
    Peter Hedera
    Department of Neurology, University of Michigan, Ann Arbor, USA
    Ann Neurol 51:45-50. 2002
    ..The syndrome we describe, designated X-linked mental retardation and epilepsy, is clinically and genetically distinct from X-linked West syndrome and other X-linked mental retardation-epilepsy syndromes...
  25. ncbi Efficacy of topiramate in children with refractory status epilepticus
    Mustafa Kahriman
    Department of Neurology, University of Michigan Health System, Ann Arbor, Michigan 48109, USA
    Epilepsia 44:1353-6. 2003
    ..CONCLUSIONS: These results support the potential efficacy of TPM for children with refractory SE. Larger prospective series are needed to confirm those results...
  26. ncbi Conversion to monotherapy: clinical trials in patients with refractory partial seizures
    Ahmad Beydoun
    Department of Neurology, University of Michigan Health System, Ann Arbor, MI 48109, USA
    Neurology 60:S13-25. 2003
    ....
  27. ncbi Mechanistic stratification of antineuralgic agents
    Ahmad Beydoun
    Department of Neurology, University of Michigan Medical School, Ann Arbor, MI 48109, USA
    J Pain Symptom Manage 25:S18-30. 2003
    ....
  28. ncbi Adjunctive clinical trials in epilepsy: is a placebo arm necessary?
    Ahmad Beydoun
    Epilepsy Behav 4:4-5. 2003